Ghisallo Capital Management’s Genenta Science GNTA Stock Holding History

Ghisallo Capital Management’s Portfolio GNTA Stock Details GNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-323,797	Closed	-$482K	–	283
2025 Q4	$482K	Buy	+323,797	New	+$762K	0.02%	196

Other funds holding GNTA

Eurizon Capital SGR SpA Milan $37.3B AUM

Allianz Munich, Germany $9.48B AUM 23.58% 1-Year Est. Return

AlTi Global New York $4.84B AUM 25.68% 1-Year Est. Return

SmartHarvest Portfolios Poulsbo, Washington $309M AUM

Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Simplicity Wealth Summit, New Jersey $2.96B AUM 25.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ghisallo Capital Management's GNTA Position: Q1 2026 in Review

Ghisallo Capital Management sold out of Genenta Science (GNTA) in Q1 2026, closing a stake of 323,797 shares — an estimated $482K sold.

Ghisallo Capital Management first reported a position in GNTA in Q4 2025 and held it in 1 quarter. The position peaked at $482K in Q4 2025. 11 funds tracked by Wall St. Rank hold GNTA as of Q1 2026.

Ghisallo Capital Management reported no remaining Genenta Science position as of Q1 2026 after selling out during the quarter.
Ghisallo Capital Management sold 323,797 Genenta Science shares in Q1 2026, an estimated $482K.
Ghisallo Capital Management first reported a position in Genenta Science in Q4 2025 and held it in 1 quarter.
Ghisallo Capital Management's Genenta Science position peaked at $482K in Q4 2025.
11 funds tracked by Wall St. Rank held Genenta Science as of Q1 2026.

Based on Ghisallo Capital Management's 13F filing for Q1 2026, filed 15 May 2026.